Crystal structure of (E)-4-(6-(4-(2-(pyridin-4-yl)vinyl)phenoxy)pyrimidin-4-yl)morpholine, C21H20N4O2

C21H20N4O2, triclinic, P1‾$\overline{1}$ (no. 2), a = 5.874(3) Å, b = 16.526(7) Å, c = 20.147(8) Å, α = 67.140(5)°, β = 83.287(6)°, γ = 86.910(6)°, V = 1789.7(14) Å3, Z = 4, Rgt(F) = 0.0614, wRref(F2) = 0.1675, T = 296 K.

Bibliographic Details
Main Authors: Bai Su-Fen, Liu Jia-Xuan, Li Shan-Shan, Tian Chun-Yu, La Xiao-Jin
Format: Article
Language:English
Published: De Gruyter 2022-08-01
Series:Zeitschrift für Kristallographie - New Crystal Structures
Subjects:
Online Access:https://doi.org/10.1515/ncrs-2022-0045